Next Article in Journal
π-Conjugated Polymer Nanoparticles from Design, Synthesis to Biomedical Applications: Sensing, Imaging, and Therapy
Next Article in Special Issue
Viability and Virulence of Listeria monocytogenes in Poultry
Previous Article in Journal
The Pathogenicity of Fusobacterium nucleatum Modulated by Dietary Fibers—A Possible Missing Link between the Dietary Composition and the Risk of Colorectal Cancer
Previous Article in Special Issue
Bacillus cereus in the Artisanal Cheese Production Chain in Southwestern Mexico
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 11
Issue 8
10.3390/microorganisms11082005
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

High Levels of Antibiotic Resistance in MDR-Strong Biofilm-Forming Salmonella Typhimurium ST34 in Southern China

by
Yuan Gao
1,2,3,4,5,6,
Kaifeng Chen
1,2,3,4,
Runshan Lin
1,2,3,4,
Xuebin Xu
7,
Fengxiang Xu
1,2,3,4,
Qijie Lin
1,2,3,4,
Yaping Hu
1,2,3,4,
Hongxia Zhang
1,2,3,4,
Jianmin Zhang
1,2,3,4,
Ming Liao
1,2,3,4,7,* and
Xiaoyun Qu
1,2,3,4,8,*
1
National and Regional Joint Engineering Laboratory for Medicament of Zoonoses Prevention and Control, Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou 510642, China
2
Key Laboratory of Zoonoses, Ministry of Agriculture, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
3
Key Laboratory of Zoonoses Prevention and Control of Guangdong Province, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
4
Animal Infectious Diseases Laboratory, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
5
Faculty of Health Sciences, University of Macau, Macau SAR 999078, China
6
CAS Key Laboratory of Pathogenic Microbiology & Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China
7
Department of Microbiology, Shanghai Municipal Centre for Disease Control and Prevention, Shanghai 200015, China
8
Key Laboratory of Livestock Disease Prevention of Guangdong Province (YDWS202204), Guangzhou 510642, China
*
Authors to whom correspondence should be addressed.
Microorganisms 2023, 11(8), 2005; https://doi.org/10.3390/microorganisms11082005
Submission received: 21 June 2023 / Revised: 29 July 2023 / Accepted: 1 August 2023 / Published: 3 August 2023
(This article belongs to the Special Issue Antibiotic Resistance and Virulence Factors of Bacteria Isolated from Food)
Browse Figure
Review Reports Versions Notes

Abstract

:
Salmonella enterica subsp. enterica serovar Typhimurium (S. typhimurium) is an important zoonotic pathogen with important public health significance. To understand S. typhimurium’s epidemiological characteristics in China, multi-locus sequence typing, biofilm-forming ability, antimicrobial susceptibility testing, and resistant genes of isolates from different regions and sources (human, food) were investigated. Among them, ST34 accounted for 82.4% (243/295), with ST19 ranking second (15.9%; 47/295). ST34 exhibited higher resistance levels than ST19 (p < 0.05). All colistin, carbapenem, and ciprofloxacin-resistant strains were ST34, as were most cephalosporin-resistant strains (88.9%; 32/36). Overall, 91.4% (222/243) ST34 isolates were shown to have multidrug resistance (MDR), while 53.2% (25/47) ST19 isolates were (p < 0.05). Notably, 97.8% (45/46) of the MDR-ACSSuT (resistance to Ampicillin, Chloramphenicol, Streptomycin, Sulfamethoxazole, and Tetracycline) isolates were ST34, among which 69.6% (32/46) of ST34 isolates were of human origin, while 30.4% (14/46) were derived from food (p < 0.05). Moreover, 88.48% (215/243) ST34 showed moderate to strong biofilm-forming ability compared with 10.9% (5/46) ST19 isolates (p < 0.01). This study revealed the emergence of high-level antibiotic resistance S. typhimurium ST34 with strong biofilm-forming ability, posing concerns for public health safety.

1. Introduction

Salmonella is a food-borne pathogen with a broad range of host tropism, causing more than 90 million cases of salmonellosis annually worldwide. There are over 2500 Salmonella serotypes identified around the world, among which Salmonella enterica subsp. enterica serovar Typhimurium (S. typhimurium) is one of the most prevalent and widely distributed in China, with numerous hosts [1]. Transmission through contaminated food, such as pork and poultry, is the main route of S. typhimurium human and animal infections. The mortality in relation to S. typhimurium is three times higher than that associated with other Salmonella serotypes [2]. Therefore, the dispersal of S. typhimurium deserves more attention.
Multi-locus sequence typing (MLST), based on bacterial housekeeping genes, is one of the methods used to investigate the genetic characteristics of S. typhimurium strains and further elucidate their transmission routes. A total of 63 S. typhimurium sequence types (STs) have been found globally, including ST34 (57%) and ST19 (28.4%) [3]. Various STs of S. typhimurium exhibit different levels of pathogenicity and drug resistance. According to an analysis of S. typhimurium based on Enterobase database, in recent years, the prevalence of different STs of S. typhimurium in the world has changed significantly, including the predominant STs [4,5,6]. Thus, it is crucial to examine the prevalence patterns of S. typhimurium STs for their effective prevention and control.
However, the prevention and control of S. typhimurium is challenging because of the rapid development of drug resistance caused by the overuse of antibiotics [7]. The emergence and spread of multidrug resistance (MDR, defined as resistance to more than three classes of drugs) in S. typhimurium pose a severe threat to humans via foodborne infection [8,9,10]. Significant regional disparities in the antibiotic resistance patterns of bacteria have been demonstrated in China [11]. The prevalence of multidrug-resistant Salmonella has increased dramatically over the past decade, with MDR-S. typhimurium posing therapeutic problems because of escalating morbidity and mortality [12]. Worse still, the MDR-ACSSuT resistance pattern (defined as resistance to Ampicillin, Chloramphenicol, Streptomycin, Sulfamethoxazole, and Tetracycline) is related to death rates that are 4.8 times greater than that from infection with non-MDR-ACSSuT strains [13]. In addition to drug resistance at the cellular level, S. typhimurium acquires adaptive resistance, such as biofilms. Studies have shown that the production of biofilms enhances the drug resistance of strains [14]. Additionally, several recent investigations have reported the emergence of virulent multidrug-resistant bacterial pathogens of different origins, increasing the necessity of the proper use of antibiotics as well as the application of rapid accurate diagnostic tools for the screening of emerging virulent MDR strains [15,16,17].
In Guangdong, Shanghai, China, S. typhimurium ranked first or second in recent years [18,19]. Previous research mainly focused on one province in China; therefore, typical southern provinces were chosen for this study. To acquire a greater understanding of S. typhimurium prevalence in China, it is necessary to investigate the relationship between drug resistance, biofilm formation capacities, and STs with diverse epidemic patterns. Therefore, in this study, we investigated the drug resistance and biofilm-forming capabilities of different STs of S. typhimurium collected between 2007 and 2017 from various regions and sources (human, food) in China.

2. Materials and Methods

2.1. Specimen Collection and Isolate Identification

The Salmonella strains used in this study were collected from five provinces, including Shanghai, Guangdong, Guangxi, Chongqing, and Sichuan from 2007 to 2017. Clinical Salmonella strains were provided by the provincial Centers for Disease Control and regional hospitals. Food and environmental samples were collected from a retail market and slaughterhouses. Salmonella was isolated according to the U.S. FDA Bacteriological Analytical Manual [20]. Isolates with typical Salmonella phenotypes were further confirmed using API identification kits (bioMérieux, Durham, NC, USA), and O and H antigens were characterized using slide agglutination with salmonella diagnostic serum (S & A Reagents Lab, Bangkok, Thailand). The serological determination of Salmonella serotypes was performed in accordance with the Kauffmann–White scheme [21].

2.2. Polymerase Chain Reaction (PCR) Amplification and Multi-Locus Sequence Typing (MLST)

Genomic DNA was isolated using the InstaGene Matrix (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s protocol. All primer sequences for amplification and sequencing were obtained from the MLST Databases of the University of Warwick (www.mlst.warwick.ac.uk/mlst/dbs/Senterica, accessed on 21 June 2023). The PCR cycling conditions were as indicated in instructions posted on the website. The PCR products were purified using Sephadex G-50 fine resin (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). Nucleotide cycle-sequencing was performed directly on purified PCR templates using automated Sanger dideoxy chain termination methods and the primers described on the MLST website. Sequences of seven housekeeping genes (aroC, dnaN, hemD, hisD, purE, sucA, and thrA) were compared with those in the MLST database (http://mlst.warwick.ac.uk/mlst/dbs/Senterica accessed on 21 June 2023) to obtain the allele number and sequence type (ST) number for each isolate. Sequence information for newly assigned alleles and STs was deposited in the MLST database [17].

2.3. Antimicrobial Susceptibility Testing

The detection of S. typhimurium susceptibility to antimicrobials was carried out using the Agar dilution method as described by the Clinical and Laboratory Standards Institute [22]. The following antibiotics (Oxoid, Basingstoke, UK) were used. β lactams antibiotics: ampicillin (AMP), cefepime (FEP), cefotaxime (CTX). Aminoglycosides antibiotics: gentamicin (GEN) and amikacin (AK). Fluroquinolone antibiotics: ciprofloxacin (CIP), ofloxacin (OFX), and nalidixic acid (NAL). Amphenicol antibiotics: chloramphenicol (C) and florfenicol (FFC). Carbapenems antibiotic: imipenem (IPM). Colistin antibiotic: polymyxin B (PB). Streptomycin antibiotic: streptomycin (STR). Sulfonamides antibiotic: sulfisoxazole (SUL). Tetracyclines antibiotic: tetracycline (TET). Escherichia coli ATCC 25,922 served as the control. The results of antibiotic sensitivity were assessed according to the CLSI criteria [22].

2.4. Detection of Biofilm Formation Ability

Biofilm production was assessed using a previously described protocol with some modifications [18]. Briefly, overnight bacterial cultures were grown at 37 °C with shaking and adjusted to give an optical density (OD570 nm) of 0.01 via dilution with (1:10) tryptic soy broth (TSB). A 100 μL volume of bacterial suspension was added to each well of a 96-well plate and incubated at 28 °C for 48 h without shaking. The medium was then discarded, and each well was washed with water and stained with 100 μL of crystal violet for 15 min. Finally, the wells were washed three times with water, and biofilm formation was assayed via the addition of 100 μL of 95% ethanol to measure the OD 570 nm. Each isolate was assayed in eight individual replicates. The negative controls contained only 100 μL of diluted TSB according to the data obtained in the present investigation and the suggested criteria [19]. Strains were classified into one of four categories: non-biofilm producers, weak biofilm producers, moderate biofilm producers, or strong biofilm producers.

2.5. Detection of Resistance Genes and Mutations

Chromosome fluoroquinolone regulatory mutations (gyrA and parC) were analyzed using PCR and sequencing. Plasmid-mediated resistance genes, including oqxAB, qepA, aac(6′)-Ib, qnrA, qnrB, qnrC, qnrD, and qnrS (fluoroquinolone resistance genes); blaSHV, blaNDM-5, blaOXA-1, blaCTX m group, and blaOXA (β-lactamase genes); and mcr-1 (colistin resistant gene) were analyzed using PCR [23]. The total DNA of Salmonella was used as a template for PCR amplification, and the amplification products were detected using agarose gel electrophoresis.

2.6. Statistical Analysis

The comparison of frequencies was calculated by using the chi-squared test using SAS 9.2 (SAS Institute, Cary, NC, USA). A p-value < 0.05 was considered statistically significant.

3. Results

3.1. S. typhimurium Isolation and Identification

A total of 295 S. typhimurium strains were obtained from five provinces, including Shanghai (124), Guangdong (72), Guangxi (29), Chongqing (45), and Sichuan (25) from 2007 to 2017. Of the isolates, 54.9% (162/295) were isolated from patients, and 45.1% (133/295) were isolated from animal and foods samples (mostly from pork or pork products (63.9%; 85/133)).

3.2. MLST Analysis

A total of 243 (243/295; 82.4%) isolates belonged to genotype ST34, and 47 (47/295; 15.9%) isolates were ST19 (Table 1). The remaining five isolates were of human origin and belonged to ST36, ST99, and ST1557, respectively. For the clinical isolates, ST34 accounted for 81.5% (132/162), followed by ST19 (25/162; 15.4%). For the food isolates, ST34 (111/133; 83.5%) was the dominant MLST type, followed by ST19 (22/133; 16.5%). Except ST36, all the isolates belonged to eBG1 (eBrust Group).

3.3. Antimicrobial Susceptibility Testing and Distribution of MDR

The isolates showed high antimicrobial resistance to SUL (253/295; 85.8%) and TET (226/295; 76.6%), followed by florfenicol (204/295; 69.2%), AMP (201/295; 68.1%), NAL (196/295; 66.4%), C (149/295; 50.5%), and STR (146/295; 49.5%) (Table S4). In addition, the rates of resistance to CIP, CTX, and FEP were18.6% (55/295), 119% (35/295), and 1.4% (4/295), respectively. Surprisingly, 3.1% (9/295) of the isolates and 0.3% (1/295) of the isolates were resistant to PB and IPM, respectively. All the strains were susceptible to amikacin. Notably, ST34 strains exhibited stronger drug-resistant characteristics than ST19, particularly toward AMP, NAL, CIP, OFX, FFC, STR, SUL, and TET (Table S4). In addition, the isolates that exhibited resistance to CTX and PB were all ST34s. Overall, 88.9% (32/36) of the isolates that were resistant to cephalosporins were ST34s. Meanwhile, human and food origin strains displayed significantly different drug resistance characteristics, especially for AMP, CTX, STR, CIP, OFX, C, and TET (p < 0.05) (Figure 1). For the clinical isolates, 18.5% (30/162) of the them were resistant to the cephem class (FEP and CTX), while only 3.8% (5/133) of the food-derived strains were resistant to FEP and CTX. The food source isolates were mostly resistant to AMP (49.6%), NAL (66.9%), FFC (69.17%), STR (57.1%), SUL (84.2%), and TET (92.5%).
More importantly, 84.4% (249/295) of the isolates had developed multi-drug resistance (resistant to at least three classes of antibiotics, MDR ≥ 3), and 33 (33/295; 11.2%) isolates were resistant to seven classes of antibiotics (Table 2). The majority of the ST34 isolates (222/243; 91.3%) were MDR strains, in contrast to only 53.2% (25/47) of the ST19 isolates. Moreover, 16.2% (41/253) of the ST34 strains displayed MDR ≥ 6, in contrast to only 2.1% (1/47) of ST19 strains. Six ST34 strains were resistant to seven classes of antibiotics. In addition, 69.6% (32/46) of isolates from humans displayed the ACSSuT resistance pattern, in contrast to only 30.4% (14/46) of isolates from food–animal sources (p < 0.01). Notably, 45 out of 46 (97.8%) MDR-ACSSuT S. typhimurium isolates were identified as ST34 (Table S5). Among them, all the MDR-ACSSuT S. typhimurium displayed the ‘ACSSuT + FFC’ pattern. In addition, 93.4% (43/46) of strains displayed the ‘ACSSuT + NAL + FFC’ pattern and 41.3% (19/46) strains displayed the ‘ACSSuT + CIP + FFC + NAL + X’ (the number of X ≥ 0) drug resistance pattern. More importantly, 8.7% (4/46) displayed the ACSSuT + CIP + CTX + FFC + NAL + X’ (the number of X ≥ 0) pattern, which were co resistant to ciprofloxacin and cephalosporins. Furthermore, 13.0% (6/46) of ACSSuT isolates exhibited intermediate resistance to ciprofloxacin (minimum inhibitory concentration (MIC) = 2 μg/mL). In addition, 53.1% (17/32) of the human-derived ACSSuT strains were isolated from children under 2 years old, leading to severe diarrhea. Meanwhile, 56.3% (18/32) of them tended to occur in summer (June to August). Moreover, 71.4% (10/14) of the animal-derived ACSSuT strains were isolated from pork.

3.4. Biofilm Formation Ability

A total of 273 (273/295; 92.5%) isolates produced biofilms, among which 220 (220/295; 74.6%) isolates were categorized as moderate or strong biofilm producers. Specifically, 93.3% (125/134) of the human-derived isolates showed moderate and strong biofilm formation capacity, while only 82.6% (90/109) of the food-derived isolates showed moderate and strong biofilm formation capacity. The ST34 isolates of human origin had a stronger ability to form biofilms than those of food origin (Table 3). Furthermore, ST34 and ST19 displayed very different characteristics with respect to biofilm formation ability; all the ST34 isolates formed biofilms, while 38.3% (18/47) of the ST19 strains were non-biofilm producers. In addition, 215 (88.5%) ST34 isolates were classified as moderate or strong biofilm producers, in contrast to only 5 (10.6%) ST19 isolates (p < 0.01).

3.5. Detection of Antimicrobial Resistance Genes and Mutations

The results showed that all the ciprofloxacin-resistant isolates were ST34 with single mutations. Among them, 98.2% (55/56) contained a gyrA mutation. Codon 87 (94.5%; 52/55) was the main gyrA mutation observed in mutant isolates. Consequently, the most common mutation was D87N (46/56; 82.1%), followed by D87Y (6/56; 10.7%). Other gyrA mutations, such as S83F (3/56; 5.4%), were observed in only three isolates. Interestingly, there was no mutation in parC.
Four types of PMQRs (Plasmid-Mediated Quinolone Resistance genes) were detected, including oqxAB (49/56; 87.5%), aac(6′)-Ib-cr (45/56; 80.3%), qnrB (14/56; 37.5%), and qepA (0/56; 0%). Interestingly, the D87N (20/31) mutation strain trended to possess three PMQR genes—oqxAB, aac(6′)-Ib-cr, and qnrB—compared with the D87Y (1/10) strain (p < 0.01). Notably, qnrB was only detected in human-derived strains (55.3%; 21/38) and not in food-derived isolates.
In addition, the majority of (91.67%; 33/36) cephalosporin-resistant strains were ST34 isolates, of which 66.7% (24/36) were positive for ESBLs genes, including blaTEM (41.7%; 15/36), blaCTX-M (10/36; 27.8%), and blaOXA (19.4%; 7/36). Three blaCTX-M subtypes were detected, including blaCTX-M-55 (80%; 8/10), blaCTX-M-123 (10%; 1/10), and blaCTX-M-3 (10%; 1/10), respectively (Table 4). In this study, blaSHV, blaPSE, blaVEB, and blaPER genes were not found among the isolates.
In addition, all the colistin-resistant and carbapenem-resistant strains were ST34 isolates. Interestingly, 100% (9/9) of the PB-resistant strains harbored an mcr-1 gene, and one carbapenem-resistant strain harbored the blaNDM-5 gene.

4. Discussion

Non-typhoidal Salmonella enterica is one of the leading causes of food-borne diseases. In recent years, S. typhimurium has been extensively detected in patients and numerous types of foods across the globe, with a significant economic impact on food safety and public health [24].Therefore, to epidemiologically study S. typhimurium, we systematically determined the antimicrobial resistance and molecular characterization of S. typhimurium from various regions and sources (human, food) in China in order to examine the relationship between drug resistance, biofilm formation capacity, and STs with diverse epidemic patterns.
To better understand the prevalence of S. typhimurium, MLST was used for bacterial genotyping, which demonstrated that ST34 was the most widespread MLST type from human and animal–food sources in China, followed by ST19. ST34 differs from ST19 by only one allele (dnaN), in which a single base change occurs. The majority of S. typhimurium strains from several provinces in China were probably from the same founder (complex one, eG1). This was consistent with previous reports in China but totally different from that in India [6,14]. More importantly, ST34 and ST19 are the most common STs of S. I 4, [5],12:i:-, which is a monophasic variant of serovar Typhimurium whose prevalence has increased in the United States and China and whose pathogenicity is higher than past S. typhimurium [25,26]. Our results revealed that, in the past, the majority of S. typhimurium originated from ST19; however. recently, ST34 has replaced ST19 as the predominant strain.
To explore the biological characteristics of these strains and the underlying factors involved in their prevalence and spread, we analyzed the tolerance of different strains to antimicrobial factors. S. typhimurium showed high resistance to traditional antibiotics such as sulfisoxazole, tetracycline, florfenicol, ampicillin, nalidixic acid, and chloramphenicol. Worryingly, 18.64%, 11.86%, and 3.1% of the isolates in our study were resistant to ciprofloxacin, cefotaxime, and polymyxin B, respectively, significantly greater than the proportions of resistant pathogens reported in previous studies [3]. Notably, resistance to CIP, FFC, and NAL has been maintained at a higher level among S. typhimurium clinical isolates from China compared with those from other countries, which might reflect the paucity of data regarding strict adherence to dosages [27,28]. Surprisingly, an imipenem-resistant strain was identified, demonstrating that the imipenem resistance gene blaNDM-5 is mediated by a transferable plasmid [29]. Although the use of antimicrobials is not generally recommended to treat salmonellosis, fluoroquinolones and extended-spectrum β-lactams might have been commonly applied to treat salmonellosis infections in China. Thus, the prevalence and drug resistance data suggest that the bacterium has spread resistance genes to food and animal-derived products in circulation.
In our study, the isolates from patients displayed more resistance to AMP, CTX, CIP, and C antibiotics than the isolates from food. However, for the antibiotics STR, OFX, and TET, the food-derived strains were more resistant (p < 0.05). The phenomenon of differently derived strains displaying different drug resistance patterns might be caused by the different dominant STs, which indicate that different origins of S. typhimurium have their own resistant characteristics [3]. Notably, even though the food-derived strains had a lower drug resistance percentage (3.8%) for FEP and CTX than the clinical strains (18.5%), the dispersion of drug resistance to third- and fourth-generation cephalosporins in food and animals requires great attention. Additionally, the emergence of high-level drug resistant strains in food and humans indicated that the drug resistance of S. typhimurium might spread in food transportation and circulation; the strict management of veterinary medicine and human medicine should be carried out to prevent mixed use.
Based on this, we conducted a drug resistance analysis on different STs of S. typhimurium. As expected, ST34 was resistant to more antibiotic classes than ST19. Among them, the resistance rate of ST34 S. typhimurium was much higher than that in previous reports and was higher than that of the ST19 strains in this study [27]. In addition to traditional antibiotics, all the ciprofloxacin-resistant strains were ST34, and the majority (88.9%, 32/36) of cephalosporin-resistant strains were ST34. This phenomenon might be related to the epidemiology of ST34, clinical antimicrobial treatment, and management performances. Antibiotics that are used frequently and indiscriminately will positively select resistant isolates, possibly resulting in more difficulties with respect to clinical treatment. We recommend more careful surveillance with respect to different STs and antibiotics in China. In addition to resistance at the cellular level, adaptive resistance is also crucial. It is suspected that biofilm-associated infections enhance persistence and resistance to environmental stress, including antimicrobials [30]. Comparative investigations on the biofilm-forming ability of S. typhimurium from various sources and strains in China are limited.
According to our results, the capacity to form biofilms correlated with ST. Compared with other STs, ST34 was more likely to develop a biofilm, with 88.5% of isolates exhibiting moderate biofilm capacity or above, while only 10.6% of ST19 isolates showed such a biofilm capacity (p < 0.05). In comparison to a previous investigation, the proportion of ST34 biofilm development increased considerably, though further investigation is required to pinpoint the cause [3]. The formation of biofilms generates an extracellular matrix comprising cellulose and coils and provides protection for bacterial survival, which might account for the higher resistance rate of ST34 S. typhimurium [31].
Notably, 93.0% of ST34 demonstrated MDR phenotypes compared with 48.9% of ST19 [9,19], which was much higher than the reported MDR rate in S. typhimurium (56.58%) [32]. Additionally, 48.1% of the ST34 strains showed MDR ≥ six classes of antibiotics, while only 2.1% of the ST19 strains showed such resistance. Alarmingly, 13.2% of the ST34 strains were resistant to seven classes of drugs, which shows their potential to develop into XDR (Extensively Drug-Resistant) strains. Meanwhile, 97.8%(45/46) of the MDR-ACSSuT S. typhimurium isolates were identified as ST34 in our study, which was much higher than the 14.5% reported previously (Table S5) [23]. Notably, all the ACSSuT strains were resistant to florfenicol, which is a broad-spectrum antimicrobial of the chloramphenicol class for veterinary use in China. This might indicate that there is drug-resistant cross-transmission from animals to humans. In addition, quinolones and third-generation cephalosporins are considered as alternative first-line drugs to treat Salmonella infections [26]. Co-resistance to fluoroquinolones and third-generation cephalosporins is already a major public health problem. Unfortunately, 41.3% of the strains were co-resistant to quinolone and cephalosporins. It is possible that human-derived ACSSuT strains could cause severe diarrhea, particularly in children without a mature immune system. Notably, all strains displaying the ACSSuT pattern were strong biofilm producers, enhancing the bacteria’s adaptability and aiding the dissemination of drug resistance. Hence, the monitoring of these severe MDR-ACSSuT ST34 among S. Typhimurium should be strengthened to prevent their spread in China.
To facilitate a greater understanding of the fundamental factors underlying bacterial antimicrobial resistance and establish measures for its prevention, an examination of the molecular mechanisms responsible is required. For quinolone- and cephalosporin-resistant strains, their resistance is mainly attributed to mutations of quinolone resistance-determining regions (QRDRs), the plasmid-mediated quinolone resistance (PMQR) mechanism, and extended-spectrum β-Lactamases (ESBLs) in Salmonella [25,26]. Ciprofloxacin-resistant Salmonella strains usually have at least two gyrA gene mutations, along with mutations in the other topoisomerase genes [33]. However, in this study, for the ciprofloxacin-resistant ST34 strains, the majority of mutations focused on the single mutation of gyrA (98.2%; 55/56) rather than parC (0%; 0/56), which was totally different than that the S. Typhimurium isolated from the Henan province, which have more than two mutations in gyrA and parC [34]. Interestingly, there was no mutation in the parC gene, whereas Salmonella enterica subspecies enterica serovar Corvallis tend to have parC to confer a high level of ciprofloxacin resistance [35]. Meanwhile, the QRDR mutations were different from those of Salmonella enterica subspecies enterica serovar Enteritidis, where D87N (82.1%) was the dominant mutation rather than D87G, which was the dominant mutation in 55.45% of the S. Enteritis isolates, possibly reflecting the different characteristics of different strains in different regions [23]. Although PMQR genes mediate low-level resistance to quinolones, they can complement other mechanisms to promote the accumulation of target-site mutations and facilitate the selection of higher-level resistance. The results showed that oqxAB and acc6-(lb’)-cr accounted for 87.5% and 80.3% of PMQR genes, respectively, followed by qnrB (37.5%; 21/56), wherein the percentage of PMQR carriers was much higher than reported in a previous study [34]. The high proportion of QRDRs and PMQRs pose a potential threat because there will be an increased resistance to ciprofloxacin due to a concomitant increase in the selection of mutants [36].
We identified ESBL genes in the cephem-resistant isolates. Four kinds of β-lactamase resistance genes were detected. Among them, the main resistant genes were blaTEM-1 and blaCTX-M, both of which are often plasmid-borne and easily transferred, thus leading to the horizontal spread of antimicrobial resistance. Notably, in our data, 80% (8/10) of the blaCTX-M genotypes were blaCTX-M-55, which belongs to the CTX-M-1 group, exhibiting high hydrolytic activity toward cefotaxime and ceftazidime [37]. Recently, a significant and increasing prevalence of blaCTX-M-55-producing bacteria in China has been detected in both animal and human populations, leading to an increase in cefepime resistance in Salmonella [38,39]. Additionally, blaNDM-5, a rare resistance gene in Salmonella, was detected and identified as a plasmid-encoded gene in Salmonella in our previous study [29]. Such a high proportion of resistant strains and genes suggests that antibiotics should be used with caution.
Colistin is recognized as the last-resort antimicrobial agent for treating carbapenem-resistant Enterobacteriaceae (CRE) infections [40]. Mcr-1-mediated colistin resistance in bacteria is concerning because colistin is used to treat multidrug-resistant bacterial infections. The current study found that mcr-1 was present in nine colistin-resistant ST34s, suggesting that the mcr-1 gene was prevalent in humans and food sources before 2016. Among children with diarrhea, those younger than 8 years old had the highest prevalence of human-derived bacterial mcr-1 (5/6), which was supported by a previous study [41]. In China, colistin has been banned from being used in animal feed. Despite this, we discovered that three out of nine (33.3%) mcr-1-containg ST34s were of food origin from Guangdong, which might be attributed to the plasmid-mediated horizontal transmission of the mcr-1 gene. Therefore, colistin-resistant Salmonella requires better detection and careful surveillance.
In summary, among the S. typhimurium isolates, ST34 displayed high-level antibiotic resistance and MDR-strong biofilm-forming ability compare with ST19. Efforts for the prevention and management of S. typhimurium should consider the multicellular behavior of the phenotypes of such strains.

5. Conclusions

This study aimed to investigate the drug resistance and biofilm-forming capabilities of different STs of S. typhimurium isolated from human, food, and animal sources in China. Our findings revealed that ST34 was the dominant ST, exhibiting significant drug resistance to traditional and defense-line drugs compared to ST19. Furthermore, we demonstrated that ST34 possesses a higher propensity for biofilm formation, potentially enhancing its adaptability in clinical and food-related infections. Therefore, based on the high levels of antibiotic resistance emerging in MDR-strong biofilm-forming S. typhimurium ST34 in southern China, our research sheds light on the potential challenges in combating infections and highlights the urgent need for targeted intervention strategies.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11082005/s1, Table S1: Biofilm formation of the 295 S. typhimurium isolates; Table S2: Antimicrobial resistance of S. typhimurium isolates from patients; Table S3: Antimicrobial resistance in S. typhimurium isolates from food; Table S4: Antimicrobial resistance of different STs of S. typhimurium; Table S5: Drug resistance pattern of S. typhimurium ST34; Table S6: Drug resistance pattern of S. typhimurium ST19.

Author Contributions

Conceptualization, Y.G., J.Z. and X.Q.; methodology, Y.G. and K.C.; formal analysis, X.X.; investigation, Y.G., K.C., R.L., F.X., Q.L., H.Z. and Y.H.; resources, X.X., M.L. and J.Z.; data curation, Y.G.; writing—original draft preparation, Y.G.; writing—review and editing, Y.G., K.C., J.Z. and J.Z.; visualization, Y.G.; supervision, M.L. and X.Q.; project administration, M.L. and X.Q.; funding acquisition, J.Z. and M.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China [grant number 31972762]; the National Key R & D Program of China [grant number 2022YFD1800400]; Project of Key Laboratory by Ministry of Agriculture and Rural Affairs [grant number YDWS202204]; Guangdong Basic and Applied Basic Research Foundation [grant number 2021A1515010815]; Double first-class discipline promotion project [grant number 2023B10564003] the Walmart Foundation Supported by Walmart Food Safety Collaboration Center [grant numbers 61626817, SA1703162]; the National Broiler Industry Technology System Project [grant number cARS-41-G16]; the Scientific Innovation Strategy-construction of High Level Academy of Agriculture Science-Prominent Talents [grant number R2020PY-JC001]; and the Open Competition Program of Top Ten Critical Priorities of Agricultural Science and Technology Innovation for the 14th Five-Year Plan of Guangdong Province [grant number 2022SDZG02].

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kirk, M.D.; Pires, S.M.; Black, R.E.; Caipo, M.; Crump, J.A.; Devleesschauwer, B.; Dopfer, D.; Fazil, A.; Fischer-Walker, C.L.; Hald, T.; et al. World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis. PLoS Med. 2015, 12, e1001921. [Google Scholar] [CrossRef] [Green Version]
  2. Park, S.H.; Aydin, M.; Khatiwara, A.; Dolan, M.C.; Gilmore, D.F.; Bouldin, J.L.; Ahn, S.; Ricke, S.C. Current and emerging technologies for rapid detection and characterization of Salmonella in poultry and poultry products. Food Microbiol. 2014, 38, 250–262. [Google Scholar] [CrossRef] [PubMed]
  3. Li, W.; Li, Y.; Liu, Y.; Shi, X.; Jiang, M.; Lin, Y.; Qiu, Y.; Qian, Z.; Chen, Q.; Zhou, L. Clonal Expansion of Biofilm-Forming Salmonella Typhimurium ST34 with Multidrug-Resistance Phenotype in the Southern Coastal Region of China. Front. Microbiol. 2017, 8, 2090. [Google Scholar] [CrossRef] [Green Version]
  4. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J. Antimicrob. Chemother. 2013, 68, 771–777. [CrossRef] [Green Version]
  5. Hendriksen, R.S.; Vieira, A.R.; Karlsmose, S.; Lo Fo Wong, D.M.; Jensen, A.B.; Wegener, H.C.; Aarestrup, F.M. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: Results of quality assured laboratories from 2001 to 2007. Foodborne Pathog. Dis. 2011, 8, 887–900. [Google Scholar] [CrossRef] [Green Version]
  6. Biswas, S.; Li, Y.; Elbediwi, M.; Yue, M. Emergence and Dissemination of mcr-Carrying Clinically Relevant Salmonella Typhimurium Monophasic Clone ST34. Microorganisms 2019, 7, 298. [Google Scholar] [CrossRef] [Green Version]
  7. Chen, Z.; Bai, J.; Zhang, X.; Wang, S.; Chen, K.; Lin, Q.; Xu, C.; Qu, X.; Zhang, H.; Liao, M.; et al. Highly prevalent multidrug resistance and QRDR mutations in Salmonella isolated from chicken, pork and duck meat in Southern China, 2018–2019. Int. J. Food Microbiol. 2021, 340, 109055. [Google Scholar] [CrossRef]
  8. Yoke-Kqueen, C.; Learn-Han, L.; Noorzaleha, A.S.; Son, R.; Sabrina, S.; Jiun-Horng, S.; Chai-Hoon, K. Characterization of multiple-antimicrobial-resistant Salmonella enterica Subsp. enterica isolated from indigenous vegetables and poultry in Malaysia. Lett. Appl. Microbiol. 2008, 46, 318–324. [Google Scholar] [CrossRef]
  9. Li, L.; Li, R.; Qi, C.; Gao, H.; Sun, F. Mechanisms of polymyxin resistance induced by Salmonella Typhimurium in vitro. Veterinary Microbiol. 2021, 257, 109063. [Google Scholar] [CrossRef]
  10. Magiorakos, A.P.; Srinivasan, A.; Carey, R.B.; Carmeli, Y.; Falagas, M.E.; Giske, C.G.; Harbarth, S.; Hindler, J.F.; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012, 18, 268–281. [Google Scholar] [CrossRef] [Green Version]
  11. Xiao, Y.; Wei, Z.; Shen, P.; Ji, J.; Sun, Z.; Yu, H.; Zhang, T.; Ji, P.; Ni, Y.; Hu, Z.; et al. Bacterial-resistance among outpatients of county hospitals in China: Significant geographic distinctions and minor differences between central cities. Microbes Infect. 2015, 17, 417–425. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, J.; Li, Y.; Xu, X.; Liang, B.; Wu, F.; Yang, X.; Ma, Q.; Yang, C.; Hu, X.; Liu, H.; et al. Antimicrobial Resistance of Salmonella enterica Serovar Typhimurium in Shanghai, China. Front. Microbiol. 2017, 8, 510. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Molbak, K. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin. Infect. Dis. 2005, 41, 1613–1620. [Google Scholar] [CrossRef]
  14. Chen, K.; Gao, Y.; Li, L.; Zhang, W.; Li, J.; Zhou, Z.; He, H.; Chen, Z.; Liao, M.; Zhang, J. Increased Drug Resistance and Biofilm Formation Ability in ST34-Type Salmonella Typhimurium Exhibiting Multicellular Behavior in China. Front. Microbiol. 2022, 13, 876500. [Google Scholar] [CrossRef]
  15. Siddique, A.; Azim, S.; Ali, A.; Andleeb, S.; Ahsan, A.; Imran, M.; Rahman, A. Antimicrobial Resistance Profiling of Biofilm Forming Non Typhoidal Salmonella enterica Isolates from Poultry and Its Associated Food Products from Pakistan. Antibiotics 2021, 10, 785. [Google Scholar] [CrossRef]
  16. Algammal, A.M.; Abo Hashem, M.E.; Alfifi, K.J.; Al-Otaibi, A.S.; Alatawy, M.; ElTarabili, R.M.; Abd El-Ghany, W.A.; Hetta, H.F.; Hamouda, A.M.; Elewa, A.A.; et al. Sequence Analysis, Antibiogram Profile, Virulence and Antibiotic Resistance Genes of XDR and MDR Gallibacterium anatis Isolated from Layer Chickens in Egypt. Infect. Drug Resist. 2022, 15, 4321–4334. [Google Scholar] [CrossRef]
  17. Algammal, A.M.; Ibrahim, R.A.; Alfifi, K.J.; Ghabban, H.; Alghamdi, S.; Kabrah, A.; Khafagy, A.R.; Abou-Elela, G.M.; Abu-Elala, N.M.; Donadu, M.G.; et al. A First Report of Molecular Typing, Virulence Traits, and Phenotypic and Genotypic Resistance Patterns of Newly Emerging XDR and MDR Aeromonas veronii in Mugil seheli. Pathogens 2022, 11, 1262. [Google Scholar] [CrossRef] [PubMed]
  18. Sun, J.; Ke, B.; Huang, Y.; He, D.; Li, X.; Liang, Z.; Ke, C. The molecular epidemiological characteristics and genetic diversity of Salmonella Typhimurium in Guangdong, China, 2007–2011. PLoS ONE 2014, 9, e113145. [Google Scholar] [CrossRef] [Green Version]
  19. Yang, J.; Zhang, Z.; Zhou, X.; Cui, Y.; Shi, C.; Shi, X. Prevalence and Characterization of Antimicrobial Resistance in Salmonella enterica Isolates from Retail Foods in Shanghai, China. Foodborne Pathog. Dis. 2020, 17, 35–43. [Google Scholar] [CrossRef]
  20. Andrews, W.; Jacobson, A.; Hammack, T. Bacteriological Analytical Manual: Salmonella; US Food and Drug Administration: Silver Spring, MD, USA, 2014. [Google Scholar]
  21. Popoff, M.Y.; Bockemühl, J.; Gheesling, L.L. Supplement 2002 (no. 46) to the Kauffmann–White scheme. Res. Microbiol. 2004, 155, 568–570. [Google Scholar] [CrossRef]
  22. CLSI, C. Performance standards for antimicrobial susceptibility testing. Clin. Lab Stand. Inst. 2016, 35, 16–38. [Google Scholar]
  23. Ma, Y.; Li, M.; Xu, X.; Fu, Y.; Xiong, Z.; Zhang, L.; Qu, X.; Zhang, H.; Wei, Y.; Zhan, Z. High-levels of resistance to quinolone and cephalosporin antibiotics in MDR-ACSSuT Salmonella enterica serovar Enteritidis mainly isolated from patients and foods in Shanghai, China. Int. J. Food Microbiol. 2018, 286, 190–196. [Google Scholar] [CrossRef] [PubMed]
  24. Niu, T.-X.; Wang, X.-N.; Wu, H.-Y.; Bi, J.-R.; Hao, H.-S.; Hou, H.-M.; Zhang, G.-L. Transcriptomic Analysis, Motility and Biofilm Formation Characteristic s of Salmonella Typhimurium Exposed to Benzyl Isothiocyanate Tr eatment. Int. J. Mol. Sci. 2021, 21, 1025. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Long, L.; You, L.; Wang, D.; Wang, M.; Wang, J.; Bai, G.; Li, J.; Wei, X.; Li, S. Highly prevalent MDR, frequently carrying virulence genes and antimicrobial resistance genes in Salmonella enterica serovar 4,[5],12:i:- isolates from Guizhou Province, China. PLoS ONE 2022, 17, e0266443. [Google Scholar] [CrossRef]
  26. Centers for Disease Control and Prevention. NARMS: 2019 Intergrated Report Summary; Food and Drug Administration: Silver Spring, MD, USA, 2022.
  27. Campioni, F.; Moratto Bergamini, A.M.; Falcão, J.P. Genetic diversity, virulence genes and antimicrobial resistance of Sal monella Enteritidis isolated from food and humans over a 24-year perio d in Brazil. Food Microbiol. 2012, 32, 254–264. [Google Scholar] [CrossRef] [PubMed]
  28. Pérez-Moreno, M.O.; Picó-Plana, E.; de Toro, M.; Grande-Armas, J.; Quiles-Fortuny, V.; Pons, M.J.; Gomes, C.; Sáenz, Y.; Torres, C.; Ruiz, J. β-Lactamases, transferable quinolone resistance determinants, and clas s 1 integron-mediated antimicrobial resistance in human clinical Salmo nella enterica isolates of non-Typhimurium serotypes. Int. J. Med. Microbiol. 2013, 303, 25–31. [Google Scholar] [CrossRef]
  29. Gao, Y.; Wen, J.; Wang, S.; Xu, X.; Zhan, Z.; Chen, Z.; Bai, J.; Qu, X.; Zhang, H.; Zhang, J.; et al. Plasmid-Encoded blaNDM-5 Gene That Confers High-Leve l Carbapenem Resistance in Salmonella Typhimurium of Pork Origin. Infect. Drug Resist. 2020, 13, 1485–1490. [Google Scholar] [CrossRef]
  30. Bridier, A.; Sanchez-Vizuete, P.; Guilbaud, M.; Piard, J.C.; Naïtali, M.; Briandet, R. Biofilm-associated persistence of food-borne pathogens. Food Microbiol. 2015, 45, 167–178. [Google Scholar] [CrossRef]
  31. Dressaire, C.; Moreira, R.N.; Barahona, S.; Alves de Matos, A.P.; Arraiano, C.M. BolA is a transcriptional switch that turns off motility and turns on biofilm development. mBio 2015, 6, e02352-14. [Google Scholar] [CrossRef] [Green Version]
  32. Ke, B.; Sun, J.; He, D.; Li, X.; Liang, Z.; Ke, C.-W. Serovar distribution, antimicrobial resistance profiles, and PFGE typing of Salmonella enterica strains isolated from 2007–2012 in Guangdong, China. BMC Infect. Dis. 2014, 14, 338. [Google Scholar] [CrossRef]
  33. Yang, B.; Xi, M.; Cui, S.; Zhang, X.; Shen, J.; Sheng, M.; Qu, D.; Wang, X.; Meng, J. Mutations in gyrase and topoisomerase genes associated with fluoroquinolone resistance in Salmonella serovars from retail meats. Food Res. Int. 2012, 45, 935–939. [Google Scholar] [CrossRef]
  34. Dong, N.; Li, Y.; Zhao, J.; Ma, H.; Wang, J.; Liang, B.; Du, X.; Wu, F.; Xia, S.; Yang, X.; et al. The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China. BMC Infect. Dis. 2020, 20, 511. [Google Scholar] [CrossRef] [PubMed]
  35. Ma, Y.; Xu, X.; Gao, Y.; Zhan, Z.; Xu, C.; Qu, X.; Chen, Z.; Bai, J.; Liao, M.; Zhang, J. Antimicrobial resistance and molecular characterization of Salmonella enterica serovar Corvallis isolated from human patients and animal source foods in China. Int. J. Food Microbiol. 2020, 335, 108859. [Google Scholar] [CrossRef] [PubMed]
  36. Robicsek, A.; Strahilevitz, J.; Jacoby, G.A.; Macielag, M.; Abbanat, D.; Park, C.H.; Bush, K.; Hooper, D.C. Fluoroquinolone-modifying enzyme: A new adaptation of a common aminogl ycoside acetyltransferase. Nat. Med. 2006, 12, 83–88. [Google Scholar] [CrossRef] [PubMed]
  37. Kiratisin, P.; Apisarnthanarak, A.; Saifon, P.; Laesripa, C.; Kitphati, R.; Mundy, L.M. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquir ed infections in Thailand. Diagn. Microbiol. Infect. Dis. 2007, 58, 349–355. [Google Scholar] [CrossRef]
  38. Bevan, E.R.; Jones, A.M.; Hawkey, P.M. Global epidemiology of CTX-M β-lactamases: Temporal and geographical s hifts in genotype. J. Antimicrob. Chemother. 2017, 72, 2145–2155. [Google Scholar] [CrossRef] [Green Version]
  39. Fu, Y.; Xu, X.; Zhang, L.; Xiong, Z.; Ma, Y.; Wei, Y.; Chen, Z.; Bai, J.; Liao, M.; Zhang, J. Fourth Generation Cephalosporin Resistance Among Salmonella enterica Serovar Enteritidis Isolates in Shanghai, China Conferred by blaCTX-M-55 Harboring Plasmids. Front. Microbiol. 2020, 11, 910. [Google Scholar] [CrossRef]
  40. Liu, Y.-Y.; Wang, Y.; Walsh, T.R.; Yi, L.-X.; Zhang, R.; Spencer, J.; Doi, Y.; Tian, G.; Dong, B.; Huang, X.; et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in a nimals and human beings in China: A microbiological and molecular biol ogical study. Lancet Infect. Dis. 2016, 16, 161–168. [Google Scholar] [CrossRef]
  41. Lu, X.; Zeng, M.; Xu, J.; Zhou, H.; Gu, B.; Li, Z.; Jin, H.; Wang, X.; Zhang, W.; Hu, Y.; et al. Epidemiologic and genomic insights on mcr-1-harbouring Salmonella from diarrhoeal outpatients in Shanghai, China, 2006–2016. EBioMedicine 2019, 42, 133–144. [Google Scholar] [CrossRef] [Green Version]
Microorganisms 11 02005 g001
Figure 1. Drug resistance of S. Typhimurium of different origins. The isolates derived from patients were significantly resistant to AMP, C, CIP, and CTX. The food-derived isolates are more resistant to STR, OFX, and TET. The y-axis shows the resistance percentage for different antibiotics. *** p < 0.01; ** p < 0.05. AMP, Ampicillin; Sulfamethoxazole; C, Chloramphenicol; CIP, Ciprofloxacin; CTX, Cefotaxime; STR, Streptomycin; OFX, Ofloxacin; and TET, Tetracycline.
Figure 1. Drug resistance of S. Typhimurium of different origins. The isolates derived from patients were significantly resistant to AMP, C, CIP, and CTX. The food-derived isolates are more resistant to STR, OFX, and TET. The y-axis shows the resistance percentage for different antibiotics. *** p < 0.01; ** p < 0.05. AMP, Ampicillin; Sulfamethoxazole; C, Chloramphenicol; CIP, Ciprofloxacin; CTX, Cefotaxime; STR, Streptomycin; OFX, Ofloxacin; and TET, Tetracycline.
Microorganisms 11 02005 g001
Table 1. MLST sequence typing of 295 S. typhimurium isolates.
Table 1. MLST sequence typing of 295 S. typhimurium isolates.
STseBGSourcesIsolates NumberPercentage
ST341Human (132), food (111)24382.4%
ST191Human (25), food (22)4715.9%
ST36138Human (2)20.7%
ST991Human (1)10.3%
ST15571Human (2)20.7%
Table 2. Resistance to multiple antibiotic classes of the 295 S. typhimurium isolates.
Table 2. Resistance to multiple antibiotic classes of the 295 S. typhimurium isolates.
Number of Antibiotic Classes They Exhibited Resistance toSourcesTotal
Food (%)Human (%)
ST19ST34ST19ST34ST36ST99ST1557
03 (13.64%)0 (0.00%)5 (20.00%)0 (0.00%)0109 (3.05%)
17 (31.82%)4 (3.60%)3 (12.00%)3 (2.27%)20221 (7.12%)
23 (13.64%)3 (2.70%)3 (12.00%)7 (5.30%)00016 (5.42%)
≥39 (40.91%)105 (94.59%)14 (56.00%)121 (91.67%)000249 (84.41%)
35 (22.73%)15 (13.51%)4 (16.00%)22 (16.67%)00046 (15.59%)
42 (9.09%)16 (14.41%)6 (24.00%)12 (9.09%)00036 (12.20%)
52 (9.09%)19 (17.12%)3 (12.00%)25 (18.94%)00049 (16.61%)
60 (0.00%)41 (36.94%)0 (0.00%)44 (33.33%)00085 (28.81%)
70 (0.00%)14 (12.61%)1 (4.00%)18 (13.64%)00033 (11.19%)
Total22 (100.00%)111 (100.00%)25 (100.00%)132 (100.00%)212295 (100.00%)
Table 3. Biofilm formation capacities of the total 295 S. Typhimurium isolates.
Table 3. Biofilm formation capacities of the total 295 S. Typhimurium isolates.
STsST34ST19ST36ST99ST1557Total
SourcesFoodHumanFoodHumanHuman
Biofilm FormationAbilityNone0 (0.00%)0 (0.00%)6 (27.27%)12 (48.00%)11222 (7.46%)
Weak19 (17.43%)9 (6.72%)14 (63.64%)10 (40.00%) 273 (92.54%)
Moderate8 (7.34%)30 (22.39%)2 (9.09%)2 (8.00%)1
Strong82 (75.23%)95 (70.90%)0 (0.00%)1 (4.00%)
Total1091342225212295
Table 4. The antimicrobial-resistant genes of S. Typhimurium isolates.
Table 4. The antimicrobial-resistant genes of S. Typhimurium isolates.
Resistance ClassificationGenesMutationProportion (%)
PMQR (plasmid-mediated
quinolone resistance)		qnrA 0.0% (0/56)
qnrB 37.5% (21/56)
qnrC 0.0% (0/56)
qnrD 0.0% (0/56)
qnrS 0.0% (0/56)
acc6-(lb’)-cr 80.3% (45/56)
oqxAB 87.5% (49/56)
qepA 0% (0/56)
QRDR (quinolone resistance-determining region)gyrAD(Asp)87N(Asn)82.1% (46/56)
D(Asp)87Y(Tyr)10.7% (6/56)
S(Ser)83F(Phe)5.4% (3/56)
No mutation0.2% (1/56)
parCNo mutation100.0% (56/56)
β-lactamsblaCTX-M 27.8% (10/36)
blaTEM 41.7% (15/36)
blaOXA 19.4% (7/36)
CarbapenemblaNDM-5 100% (1/1)
Colistinmcr-1 100% (9/9)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gao, Y.; Chen, K.; Lin, R.; Xu, X.; Xu, F.; Lin, Q.; Hu, Y.; Zhang, H.; Zhang, J.; Liao, M.; et al. High Levels of Antibiotic Resistance in MDR-Strong Biofilm-Forming Salmonella Typhimurium ST34 in Southern China. Microorganisms 2023, 11, 2005. https://doi.org/10.3390/microorganisms11082005

AMA Style

Gao Y, Chen K, Lin R, Xu X, Xu F, Lin Q, Hu Y, Zhang H, Zhang J, Liao M, et al. High Levels of Antibiotic Resistance in MDR-Strong Biofilm-Forming Salmonella Typhimurium ST34 in Southern China. Microorganisms. 2023; 11(8):2005. https://doi.org/10.3390/microorganisms11082005

Chicago/Turabian Style

Gao, Yuan, Kaifeng Chen, Runshan Lin, Xuebin Xu, Fengxiang Xu, Qijie Lin, Yaping Hu, Hongxia Zhang, Jianmin Zhang, Ming Liao, and et al. 2023. "High Levels of Antibiotic Resistance in MDR-Strong Biofilm-Forming Salmonella Typhimurium ST34 in Southern China" Microorganisms 11, no. 8: 2005. https://doi.org/10.3390/microorganisms11082005

APA Style

Gao, Y., Chen, K., Lin, R., Xu, X., Xu, F., Lin, Q., Hu, Y., Zhang, H., Zhang, J., Liao, M., & Qu, X. (2023). High Levels of Antibiotic Resistance in MDR-Strong Biofilm-Forming Salmonella Typhimurium ST34 in Southern China. Microorganisms, 11(8), 2005. https://doi.org/10.3390/microorganisms11082005

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop